ClinVar Miner

Submissions for variant NM_005732.4(RAD50):c.1631_1635+1del

dbSNP: rs1235022794
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Ambry Genetics RCV000573500 SCV000663634 uncertain significance Hereditary cancer-predisposing syndrome 2021-09-10 criteria provided, single submitter clinical testing The c.1631_1635+1delACAAAG variant is located between coding exon 10 and intron 10 of the RAD50 gene. This variant results from a deletion of 6 nucleotides at positions 1631 to 1635+1. This deletion includes the canonical splice donor site, which makes it likely to have some effect on normal mRNA splicing. These nucleotide positions are generally well conserved in available vertebrate species. In silico splice site analysis predicts that this alteration will result in the creation or strengthening of a novel splice donor site. RNA studies have demonstrated that this alteration results in a transcript predicted to lead to a protein with an in-frame deletion of two amino acids; however, the exact functional impact of the deleted amino acids are unknown at this time (Ambry internal data). Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.
Invitae RCV000573500 SCV000753333 uncertain significance Hereditary cancer-predisposing syndrome 2022-10-19 criteria provided, single submitter clinical testing Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. ClinVar contains an entry for this variant (Variation ID: 480403). This variant is also known as c.1631_1635+1del. This variant has not been reported in the literature in individuals affected with RAD50-related conditions. This variant is present in population databases (no rsID available, gnomAD 0.06%). This variant, c.1630_1635del, results in the deletion of 2 amino acid(s) of the RAD50 protein (p.Asp544_Lys545del), but otherwise preserves the integrity of the reading frame. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Revvity Omics, Revvity RCV001783068 SCV002019619 pathogenic Nijmegen breakage syndrome-like disorder 2019-07-14 criteria provided, single submitter clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.